CHIASMA
Summary
Chiasma operates as a biopharmaceutical company. The Company develops pharmaceutical products for the treatment of acromegaly and hormonal disorders. Chiasma serves patients in the United States.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 196 M
Avg. Deal Size£ 196 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
